541 related articles for article (PubMed ID: 29149058)
1. Neurotrophic and Neuroregenerative Effects of GH/IGF1.
Bianchi VE; Locatelli V; Rizzi L
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29149058
[TBL] [Abstract][Full Text] [Related]
2. The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features.
Pellecchia MT; Pivonello R; Monsurrò MR; Trojsi F; Longo K; Piccirillo G; Pivonello C; Rocco M; Di Somma C; Colao A; Tedeschi G; Barone P
Eur J Neurol; 2010 May; 17(5):666-71. PubMed ID: 20002733
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis.
Sakowski SA; Schuyler AD; Feldman EL
Amyotroph Lateral Scler; 2009 Apr; 10(2):63-73. PubMed ID: 18608100
[TBL] [Abstract][Full Text] [Related]
4. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain.
Aberg ND; Brywe KG; Isgaard J
ScientificWorldJournal; 2006 Jan; 6():53-80. PubMed ID: 16432628
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor system in amyotrophic lateral sclerosis.
Wilczak N; Keyser J
Endocr Dev; 2005; 9():160-169. PubMed ID: 15879696
[TBL] [Abstract][Full Text] [Related]
6. Impairments to the GH-IGF-I axis in hSOD1G93A mice give insight into possible mechanisms of GH dysregulation in patients with amyotrophic lateral sclerosis.
Steyn FJ; Ngo ST; Lee JD; Leong JW; Buckley AJ; Veldhuis JD; McCombe PA; Chen C; Bellingham MC
Endocrinology; 2012 Aug; 153(8):3735-46. PubMed ID: 22621959
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I: potential for treatment of motor neuronal disorders.
Lewis ME; Neff NT; Contreras PC; Stong DB; Oppenheim RW; Grebow PE; Vaught JL
Exp Neurol; 1993 Nov; 124(1):73-88. PubMed ID: 8282084
[TBL] [Abstract][Full Text] [Related]
8. Role of growth hormone (GH) in the treatment on neural diseases: from neuroprotection to neural repair.
Arce VM; Devesa P; Devesa J
Neurosci Res; 2013 Aug; 76(4):179-86. PubMed ID: 23602740
[TBL] [Abstract][Full Text] [Related]
9. Nanowired Delivery of Growth Hormone Attenuates Pathophysiology of Spinal Cord Injury and Enhances Insulin-Like Growth Factor-1 Concentration in the Plasma and the Spinal Cord.
Muresanu DF; Sharma A; Lafuente JV; Patnaik R; Tian ZR; Nyberg F; Sharma HS
Mol Neurobiol; 2015 Oct; 52(2):837-45. PubMed ID: 26126514
[TBL] [Abstract][Full Text] [Related]
10. Mecasermin (recombinant human insulin-like growth factor I).
Rosenbloom AL
Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
[TBL] [Abstract][Full Text] [Related]
11. Brain-Derived Neurotrophic Factor Facilitates Functional Recovery from ALS-Cerebral Spinal Fluid-Induced Neurodegenerative Changes in the NSC-34 Motor Neuron Cell Line.
Shruthi S; Sumitha R; Varghese AM; Ashok S; Chandrasekhar Sagar BK; Sathyaprabha TN; Nalini A; Kramer BW; Raju TR; Vijayalakshmi K; Alladi PA
Neurodegener Dis; 2017; 17(1):44-58. PubMed ID: 27617773
[TBL] [Abstract][Full Text] [Related]
12. Protective and regenerative effects of the GH/IGF-I axis on the brain.
Isgaard J; Aberg D; Nilsson M
Minerva Endocrinol; 2007 Jun; 32(2):103-13. PubMed ID: 17557036
[TBL] [Abstract][Full Text] [Related]
13. Combined growth hormone (GH) and insulin-like growth factor-I (IGF-I) treatment is more effective than GH or IGF-I alone at enhancing recovery from neonatal malnutrition in rats.
Zhao X; Donovan SM
J Nutr; 1995 Nov; 125(11):2773-86. PubMed ID: 7472657
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers.
de Boer H; Blok GJ; Popp-Snijders C; Stuurman L; Baxter RC; van der Veen E
J Clin Endocrinol Metab; 1996 Apr; 81(4):1371-7. PubMed ID: 8636336
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone secretion is correlated with neuromuscular innervation rather than motor neuron number in early-symptomatic male amyotrophic lateral sclerosis mice.
Steyn FJ; Lee K; Fogarty MJ; Veldhuis JD; McCombe PA; Bellingham MC; Ngo ST; Chen C
Endocrinology; 2013 Dec; 154(12):4695-706. PubMed ID: 24108071
[TBL] [Abstract][Full Text] [Related]
16. The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis.
Torres-Aleman I; Barrios V; Berciano J
Neurology; 1998 Mar; 50(3):772-6. PubMed ID: 9521273
[TBL] [Abstract][Full Text] [Related]
17. The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.
Messi ML; Clark HM; Prevette DM; Oppenheim RW; Delbono O
Exp Neurol; 2007 Sep; 207(1):52-63. PubMed ID: 17597610
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis.
Rauskolb S; Dombert B; Sendtner M
Neurobiol Dis; 2017 Jan; 97(Pt B):103-113. PubMed ID: 27142684
[TBL] [Abstract][Full Text] [Related]
19. The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males.
Fisker S; Nørrelund H; Juul A; Skakkebaek NE; Christiansen JS; Jørgensen JO
Growth Horm IGF Res; 2001 Apr; 11(2):104-9. PubMed ID: 11472076
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone secretion is impaired in amyotrophic lateral sclerosis.
Morselli LL; Bongioanni P; Genovesi M; Licitra R; Rossi B; Murri L; Rossi G; Martino E; Gasperi M
Clin Endocrinol (Oxf); 2006 Sep; 65(3):385-8. PubMed ID: 16918961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
